Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $17.2100 (3.12%) ($17.2100 - $17.2100) on Wed. Feb. 24, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.08% (three month average) | RSI | 37 | Latest Price | $17.2100(3.12%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1.2% a day on average for past five trading days. | Weekly Trend | ATRA declines -6.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(45%) ARKK(44%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -1.54% in a week (0% probabilities). VIXM(-35%) VXX(-27%) IGOV(-15%) UNG(-11%) UUP(-9%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.54% (StdDev 3.08%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $7.1(-58.74%) | Inflection Point | Yes | Resistance Level | $18.71 | 5 Day Moving Average | $17.35(-0.81%) | 10 Day Moving Average | $18.01(-4.44%) | 20 Day Moving Average | $18.71(-8.02%) | To recent high | -34.6% | To recent low | 3.1% | Market Cap | $1.279b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |